These highlights do not include all the information needed to use VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA dyspepsia, abnormal vision, nasal congestion, back pain, myalgia, nausea, dizziness and rash . To report SUSPECTED ADVERSE REACTIONS, contact Pfizer at or FDA at FDA-1088
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use PLETAL safely and effectively. See full prescribing information for PLETAL. PLETAL America Pharmaceutical, Inc. at or FDA at FDA
See package insert for FDA prescribing information: 14 Uzedy prescribing information. Teva Neuroscience, Inc. May 2024. 15
Patient Information - Spanish. PRESCRIBING INFORMATION; Prescribing You are encouraged to report negative side effects of prescription drugs to the FDA.
FDA-approved patient labeling. Revised: 1/2025 FULL PRESCRIBING INFORMATION: CONTENTS 1 INDICATIONS AND USAGE Sildenafil is also marketed as VIAGRA
VIAGRA safely and effectively. See full prescribing information for VIAGRA. VIAGRA (sildenafil citrate) tablets, for oral use contact Pfizer at - or FDA at 1 FDA1088 or .
According to Viagra s (see important safety information) FDA-approved prescribing information, between 63% and 82% of patients reported an improvement in their erections after taking Viagra. Other PDE5 inhibitors work in a similar way in the body and are also effective.
References: Viagra ODT (sildenafil citrate) Prescribing Information: Version January 2025.; Viagra (sildenafil citrate) Prescribing Information: Version January
Historic Medicines ; Prescribing Information Gemzar withdrawn from FDA Prescribing Information ; Medication Guide
Comments
What the hell would the FDA have to do with it? This is a piece of machinery. They would have NO say about it whatsoever.